Resources & Insights

PharPoint Research > Resources & Insights
Evolving regulations and virtual trials
PharPoint's Clinical Operations Director on COVID-19 and Virtual Trials As the FDA continues to develop evolving guidelines, our industry has experienced a sudden, paradigm shift with telemedicine becoming the “norm” for patient interaction across a variety of therapeutic areas. PharPoint is a strong advocate of this approach as an option to incorporate efficiencies for select...
April 21, 2020
No Comments
COVID-19: Update from PharPoint Research
COVID-19: Update from PharPoint Research As the situation with COVID-19 evolves, the PharPoint Research team is taking necessary precautions to ensure study operations continue uninterrupted. During this critical time in our industry, PharPoint remains fully dedicated, as always, to helping clients improve global health. Our leadership team has been closely monitoring the situation since the...
March 16, 2020
No Comments
Rare Disease Day 2020

This February 29th, PharPoint acknowledges Rare Disease Day. We are relentless in supporting clients so that they may advance rare disease research and the approval of breakthrough treatments.

February 27, 2020
No Comments
Industry News: COVID-19

Information regarding the novel coronavirus is rapidly evolving as scientists and public-health officials race to uncover important details on the spread and treatment of the virus. Explore PharPoint’s news roundup and learn more about our extensive infectious disease experience.

February 4, 2020
No Comments
Ask a Clinical Trial Expert: Data Reconciliation

How do you perform non-eCRF data (ECG, Labs, PK) reconciliation in EDC platforms like Medrio? A PharPoint clinical trial expert answers as part of our #askaclinicaltrialexpert blog series.

January 9, 2020
No Comments
Ask a Clinical Trial Expert: Choosing an EDC Provider

For our upcoming study, we know we want to use EDC—but there are so many options. How should we choose an EDC provider? As part of our Ask a Clinical Trial Expert blog series, a PharPoint clinical trial expert answers.

January 9, 2020
No Comments
Ask a Clinical Trial Expert: Clinical Trial Study Rescues

We’re worried that the service providers working on our study are causing it to fall behind. Timelines are being missed due to slow enrollment and data quality is poor. What are our options? A member of the PharPoint leadership team discusses options for study rescues in this Ask a Clinical Trial Expert blog series post.

October 9, 2019
No Comments
Bridging the the gap between sponsors and service providers

What challenges exist between CROs and Sponsors—and is collaborative technology the answer, or something else?

October 9, 2019
No Comments
The benefits of employing a functional service provider for clinical data management

For years, pharmaceutical and biotechnology companies have employed the strategy of establishing preferred provider relationships in order to streamline the process of outsourcing clinical research studies. Often, the preferred provider would provide discounts to their customers based on efficiencies the service provider may realize from working on multiple trials for a single compound or the…

October 9, 2019
No Comments
Global clinical data management without global offices

This post was originally published on August 8, 2013 and updated on May 13, 2019. We are often asked by clients whether or not PharPoint Research has global Clinical Data Management capabilities. Our answer is always a resounding “Yes!” The industry tends to limit the definition of global Clinical Data Management (CDM) to the physical…

October 9, 2019
No Comments
  • 1
  • 2